ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Super Citrimax Garcinia Cambogia

Also known as: Garcinia cambogia, Malabar tamarind, Hydroxycitric acid, HCA, Super Citrimax

Overview

Garcinia cambogia is a tropical fruit, and its rind contains the active compound hydroxycitric acid (HCA). Super Citrimax is a branded extract of Garcinia cambogia standardized for its HCA content, often formulated with calcium and potassium salts to enhance stability and absorption. It is primarily marketed as a nutraceutical supplement for weight management, with additional purported benefits for glycemic control and liver health. While numerous randomized controlled trials (RCTs) and meta-analyses exist, the research maturity is moderate, and results are often heterogeneous and sometimes contradictory. The evidence quality varies, with many studies being small or having methodological limitations, leading to a nuanced understanding of its efficacy.

Benefits

Garcinia cambogia, particularly its HCA component, has been studied for several potential benefits. For weight loss, systematic reviews and meta-analyses indicate a small, statistically significant effect compared to placebo, but the clinical relevance is often questioned. For instance, a 2010 meta-analysis found only borderline significance and small effect sizes that diminished when lower-quality studies were excluded. Regarding glycemic control, a 2024 meta-analysis suggested that Garcinia cambogia might reduce insulin levels when taken for more than two months, indicating potential benefits in regulating blood sugar, though more robust trials are needed to confirm this. Other reported effects include antioxidant, anti-inflammatory, hepatoprotective, and gut microbiota-modulating properties, but these are less extensively studied in clinical settings compared to its weight loss and glycemic effects.

How it works

Hydroxycitric acid (HCA), the active compound in Garcinia cambogia, is believed to exert its effects primarily by inhibiting ATP citrate lyase. This enzyme plays a crucial role in the conversion of citrate to acetyl-CoA, a key step in de novo lipogenesis (the synthesis of new fat). By inhibiting this enzyme, HCA may reduce fat synthesis and promote fat oxidation. Additionally, HCA might influence appetite regulation by affecting serotonin pathways in the brain, although the evidence for this mechanism is more limited. The bioavailability of HCA can be variable, but formulations like Super Citrimax, which include calcium and potassium salts, are designed to improve its stability and absorption in the body.

Side effects

Garcinia cambogia is generally considered safe when consumed at recommended dosages, with a low incidence of adverse effects. The most commonly reported side effects are mild gastrointestinal symptoms, such as nausea and diarrhea, which typically resolve on their own. There have been rare, isolated reports of hepatotoxicity (liver damage), but a conclusive link to Garcinia cambogia extracts has not been firmly established in high-quality studies. No major drug interactions or contraindications have been identified in well-conducted research. However, caution is advised for individuals with pre-existing liver conditions due to the limited safety data in this specific population. It is always recommended to consult a healthcare professional before starting any new supplement, especially if you have underlying health issues or are taking other medications.

Dosage

Typical dosages of Garcinia cambogia, specifically its active component HCA, used in clinical studies range from 500 mg to 2800 mg per day. These daily doses are often divided and taken multiple times throughout the day. Super Citrimax formulations usually provide standardized HCA doses, commonly in the range of 1000-1500 mg daily. To observe potential effects, trials often administer the supplement for a duration of at least 8 weeks. It is generally recommended to take Garcinia cambogia with meals, as this may help improve its tolerability and reduce the likelihood of gastrointestinal discomfort. Always adhere to the specific dosage instructions provided on the product label or as advised by a healthcare professional.

FAQs

Is Garcinia cambogia effective for weight loss?

Evidence suggests a small, statistically significant weight loss effect compared to placebo, but its clinical relevance is often questioned and it's not comparable to pharmaceutical agents.

Is Garcinia cambogia safe to use?

It is generally considered safe, but some users may experience mild gastrointestinal symptoms. Individuals with liver disease should exercise caution due to limited safety data.

How long does it take to see results from Garcinia cambogia?

Benefits, particularly for weight and insulin levels, may require consistent use for at least two months or longer to become noticeable.

Does Garcinia cambogia suppress appetite?

It may potentially influence appetite regulation through serotonin pathways, but clinical evidence supporting significant appetite suppression is limited and inconsistent.

Research Sources

  • https://www.cambridge.org/core/services/aop-cambridge-core/content/view/37499792A0E6C19DD66C5DDF14F56D4A/S2048679024000910a.pdf/effects_of_garcinia_cambogia_on_glycaemic_control_and_liver_enzymes_in_adults_a_systematic_review_and_metaanalysis_of_randomised_controlled_trials.pdf – This 2024 systematic review and meta-analysis investigated the effects of Garcinia cambogia on glycemic control and liver enzymes. It found a significant reduction in insulin levels when taken for more than 2 months, suggesting potential benefits for glycemic regulation, though it noted the need for more robust trials due to heterogeneity and small sample sizes in included studies.
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC3010674/ – This 2011 systematic review and meta-analysis, similar to a Cochrane review, analyzed 12 randomized controlled trials on Garcinia cambogia for weight loss. It concluded that HCA was not significantly effective for weight loss compared to placebo after sensitivity analysis, highlighting that small studies influenced results and the largest RCT showed negative findings. The review was of high quality and provided a negative conclusion regarding efficacy.
  • https://pubs.acs.org/doi/10.1021/acsomega.2c02838 – This 2022 review focused on the bioactives and pharmacokinetics of Garcinia cambogia. It highlighted issues related to bioavailability, discussed other bioactivities beyond weight loss, and emphasized the critical need for quality control in Garcinia cambogia supplements. While not a clinical trial, it provides valuable insights for formulation considerations and understanding the compound's properties.
  • https://www.semanticscholar.org/paper/The-Use-of-Garcinia-Extract-(Hydroxycitric-Acid)-as-Onakpoya-Hung/ee7880a015314ef3aea17234c45a7bf1a8978cf3 – This 2010 systematic review and meta-analysis of 8 randomized controlled trials on Garcinia cambogia for weight loss found a small, borderline significant weight loss effect. However, it noted that the clinical relevance was uncertain due to small sample sizes, heterogeneity among studies, and a potential risk of bias, calling for better-designed trials.
  • https://onlinelibrary.wiley.com/doi/10.1155/2013/751658 – This 2013 narrative review provided mechanistic insights into how HCA inhibits lipogenesis, explaining its potential role in reducing fat synthesis. It discussed mixed clinical results from various studies, offering a background on the proposed biological pathways without presenting new randomized controlled trial data, making it informative for understanding the mechanism of action.